The company claims its Fertilo system can mature eggs outside the body using 80% fewer hormonal injections than typical ...

Gameto, a clinical-stage biotech company developing iPSC-based therapies for women’s health, today announced that the U.S.

application for Fertilo, to enable the launch of the first US-based Phase 3 clinical trial for an induced pluripotent stem cell (iPSC)-based therapy. This groundbreaking milestone highlights the ...